{"id":25,"date":"2014-11-06T06:54:21","date_gmt":"2014-11-06T06:54:21","guid":{"rendered":"http:\/\/staffpages.uofk.edu\/osheik-seidi\/?page_id=25"},"modified":"2014-11-06T06:54:21","modified_gmt":"2014-11-06T06:54:21","slug":"experience","status":"publish","type":"page","link":"https:\/\/staffpages.uofk.edu\/osheik-seidi\/?page_id=25","title":{"rendered":"Experience"},"content":{"rendered":"<p><strong>Experience in Clinical Trials<\/strong><\/p>\n<p><strong>I participated in the following Multi-Centre Randomised Controlled Clinical Trials (RCT\u2019s):<\/strong><\/p>\n<p><strong>These were done during my work at Guy\u2019s King\u2019s Collee and St Thomas\u2019 School of Medicine of the University of London\u00a0 &#8211; in the period from 200 to 2003<\/strong><\/p>\n<p>1- Interferon Beta for Secondary Progressive Multiple Sclerosis (PRISMS)<\/p>\n<p>2- The EVIDENCE study, Rebif versus Avonex for Relapsing Remitting RRMS (A comparative Study of 2 Preparations of Beta Interferon). I was a member of The UK-EVIDENCE trial group. (Panitch et al, 2002, Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial, Neurology, 26;59(10):1496-506).<\/p>\n<p>3-\u00a0\u00a0\u00a0\u00a0\u00a0 Antegren (Intravenous injection of Humanised antibodies to an Adhesion Molecule -Natalizumab) in Relapsing Remitting MS.<\/p>\n<p>4-\u00a0\u00a0\u00a0\u00a0\u00a0 Anakinra (Antibodies against Interleukin I receptors Injections) for MS<\/p>\n<p>5-\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0Neuroblock (Botulinum Toxin Type B Injections) for Spasticity in MS<\/p>\n<p>6-\u00a0\u00a0\u00a0\u00a0\u00a0 Oral Copolymer A- Glatiramer acetate in MS- (CORAL study)<\/p>\n<p>7-\u00a0\u00a0\u00a0\u00a0\u00a0 Zonisamide for Epilepsy\u00a0 (Add-On Treatment for Refractory Epilepsy)<\/p>\n<p>8-\u00a0\u00a0\u00a0\u00a0\u00a0 CAMS Study (Cannabinoids in MS)<\/p>\n<h2>Membership of Professional Organizations:<\/h2>\n<p>1993\u00a0\u00a0\u00a0\u00a0\u00a0 Member of the <strong>Royal<\/strong><strong> College<\/strong><strong> of Physicians of London<\/strong><\/p>\n<p>Chairman of the MRCP (UK) Examinations in Sudan<\/p>\n<p>2000\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Member of the <strong>American Academy of Neurology-<\/strong> Corresponding Associate<\/p>\n<p>2000\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Member of the <strong>Association of British Neurologists<\/strong>\u00a0 &#8211; Full Ordinary<\/p>\n<p>2000\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Member of <strong>London<\/strong><strong> Flow Cytometry Club<\/strong><\/p>\n<p>2004\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0Member of the African Neurology Interest Group \u2013 ANIG\/ABN<\/p>\n<p>2005\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0The Medical Defence Union (UK) &#8211; 3 October 2005. Membership Number: 499858B<\/p>\n<p>2008\u00a0\u00a0 \u00a0\u00a0\u00a0 Listed in \u201cWho is Who\u201d in the World 2008<\/p>\n<p><a href=\"http:\/\/bios.marquiswhoswho.com\/osheik_abuasha_seidi\/neurologist_consultant\/7682788\">http:\/\/bios.marquiswhoswho.com\/osheik_abuasha_seidi\/neurologist_consultant\/7682788<\/a><\/p>\n<p>2009\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 FRCP- London<\/p>\n<p>2013\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 FRCP \u2013 Glasgow<\/p>\n<p>2013\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0National Geographic Society<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Experience in Clinical Trials I participated in the following Multi-Centre Randomised Controlled Clinical Trials (RCT\u2019s): These were done during my [&hellip;]<\/p>\n","protected":false},"author":808,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","meta":{"footnotes":""},"class_list":["post-25","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/staffpages.uofk.edu\/osheik-seidi\/index.php?rest_route=\/wp\/v2\/pages\/25","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staffpages.uofk.edu\/osheik-seidi\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/staffpages.uofk.edu\/osheik-seidi\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/staffpages.uofk.edu\/osheik-seidi\/index.php?rest_route=\/wp\/v2\/users\/808"}],"replies":[{"embeddable":true,"href":"https:\/\/staffpages.uofk.edu\/osheik-seidi\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=25"}],"version-history":[{"count":1,"href":"https:\/\/staffpages.uofk.edu\/osheik-seidi\/index.php?rest_route=\/wp\/v2\/pages\/25\/revisions"}],"predecessor-version":[{"id":27,"href":"https:\/\/staffpages.uofk.edu\/osheik-seidi\/index.php?rest_route=\/wp\/v2\/pages\/25\/revisions\/27"}],"wp:attachment":[{"href":"https:\/\/staffpages.uofk.edu\/osheik-seidi\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=25"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}